{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:30Z","timestamp":1793924850747,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011893","name":"Pan American Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vaccine.2026.129226","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:19:23Z","timestamp":1791667163000},"page":"129226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring the broader social value outcomes reported in economic evaluations of vaccination programmes across the life course: A scoping review"],"prefix":"10.1016","volume":"94","author":[{"given":"Louise","family":"Prendergast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Begley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Savoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bast\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Cresswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Dyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129226_bb0010","article-title":"The value(s) of vaccination: building the scientific evidence according to a value-based healthcare approach","volume":"10","author":"Calabro\u2019","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2026.129226_bb0020","first-page":"39","article-title":"Association between gender inequality and population-level health outcomes: panel data analysis of organization for economic co-operation and development (OECD) countries","volume":"1","author":"Veas","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129226_bb0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.129226_bb0030","article-title":"Beyond coverage: can vaccination reduce child mortality despite structural inequality? A global ecological analysis of routine childhood immunization (2010\u22122023)","author":"Montoya","year":"2026","journal-title":"medRxiv"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129226_bb0035","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1136\/bmjgh-2022-011341","article-title":"Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study","volume":"8","author":"Kim","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"685","key":"10.1016\/j.vaccine.2026.129226_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf1093","article-title":"Vaccines for a sustainable planet","volume":"15","author":"Pecetta","year":"2023","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129226_bb0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation","volume":"116","author":"Palmer","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129226_bb0050","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study","volume":"101","author":"Chang","year":"2009","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.vaccine.2026.129226_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41562-017-0056","article-title":"On the benefits of explaining herd immunity in vaccine advocacy","volume":"1","author":"Betsch","year":"2017","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.vaccine.2026.129226_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0446-9","article-title":"The broader economic impact of vaccination: reviewing and appraising the strength of evidence","volume":"13","author":"Jit","year":"2015","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-023-10071-z","article-title":"Economic evaluations of immunization programs as an indispensable tool for policymakers","volume":"23","author":"den Boon","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"441","key":"10.1016\/j.vaccine.2026.129226_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj2345","article-title":"The broad socioeconomic benefits of vaccination","volume":"10","author":"Bloom","year":"2018","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129226_bb0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2105\/AJPH.2020.306114","article-title":"The societal value of vaccination in the age of COVID-19","volume":"111","author":"Bloom","year":"2021","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129226_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5539\/hes.v10n3p16","article-title":"Online and remote learning in higher education institutes: a necessity in light of COVID-19 pandemic","volume":"10","author":"Ali","year":"2020","journal-title":"High Educ Stud"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129226_bb0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/00220221211025100","article-title":"Impact of societal culture on Covid-19 morbidity and mortality across countries","volume":"52","author":"Kumar","year":"2021","journal-title":"J Cross Cult Psychol"},{"key":"10.1016\/j.vaccine.2026.129226_bb0105","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1016\/j.vaccine.2016.12.001","article-title":"Moving beyond traditional valuation of vaccination: needs and opportunities","volume":"35","author":"Bloom","year":"2017","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2026.129226_bb0110","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1016\/j.vaccine.2023.05.039","article-title":"The societal cost of vaccine refusal: a modelling study using measles vaccination as a case study","volume":"41","author":"Olivera Mesa","year":"2023","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129226_bb0115","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129226_bb0120","series-title":"WHO expanded programme on immunization [Internet]","author":"World Health Assembly 27","year":"1974"},{"key":"10.1016\/j.vaccine.2026.129226_bb0125","author":"Diseases Elimination Initiative - PAHO\/WHO | Pan American Health Organization [Internet]. [cited"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129226_bb0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: an analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Info Libr J"},{"key":"10.1016\/j.vaccine.2026.129226_bb0135","series-title":"Methodology for jbi scoping reviews [internet]","author":"Peters","year":"2015"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129226_bb0145","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129226_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133606","article-title":"An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model","volume":"10","author":"Chit","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129226_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225326","article-title":"Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: a pilot study","volume":"14","author":"Colamesta","year":"2019","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129226_bb0170","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s10198-023-01654-y","article-title":"Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK","volume":"25","author":"Sevilla","year":"2024","journal-title":"Eur J Health Econ"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129226_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2114252","article-title":"Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt","volume":"18","author":"Sevilla","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"S1","key":"10.1016\/j.vaccine.2026.129226_bb0180","doi-asserted-by":"crossref","first-page":"A143","DOI":"10.1016\/j.vaccine.2014.12.078","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay","volume":"33","author":"Kieninger","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129226_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vhri.2018.01.001","article-title":"Cost-effectiveness analysis of pneumococcal and influenza vaccines administered to children less than 5 years of age in a low-income district of Bogota, Colombia","volume":"17","author":"Lara","year":"2018","journal-title":"Value Health Reg Issues"},{"issue":"31","key":"10.1016\/j.vaccine.2026.129226_bb0190","doi-asserted-by":"crossref","first-page":"682","DOI":"10.15585\/mmwr.mm7331a2","article-title":"Health and economic benefits of routine childhood immunizations in the era of the vaccines for children program - United States, 1994-2023","volume":"73","author":"Zhou","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129226_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310274","article-title":"Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China","volume":"19","author":"Shen","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129226_bb0200","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/14737167.2021.1932468","article-title":"Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand","volume":"21","author":"Rochanathimoke","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129226_bb0205","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/21645515.2015.1087626","article-title":"The cost effectiveness of rotavirus vaccination in Iran","volume":"12","author":"Mousavi Jarrahi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"21","key":"10.1016\/j.vaccine.2026.129226_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126162","article-title":"Evaluation of pre-school pertussis booster vaccination in Shanghai, China: a cost-effectiveness analysis","volume":"42","author":"Ren","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129226_bb0215","doi-asserted-by":"crossref","unstructured":"Urue\u00f1a A, Pippo T, Betelu MS, Virgilio F, Hern\u00e1ndez L, Giglio N, et al. Cost-effectiveness analysis of rotavirus vaccination in Argentina. Vaccine 2015 33(S1):A126\u201334. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.074 [PubMed PMID: 25919152].","DOI":"10.1016\/j.vaccine.2014.12.074"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2026.129226_bb0220","article-title":"Cost effectiveness analysis of rotavirus vaccination in Indonesia","volume":"43","author":"Thobari","year":"2025","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2026.129226_bb0225","doi-asserted-by":"crossref","first-page":"A174","DOI":"10.1016\/j.vaccine.2014.12.042","article-title":"Cost-effectiveness of HPV vaccination in Belize","volume":"33","author":"Walwyn","year":"2015","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2026.129226_bb0230","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1016\/j.vaccine.2021.04.024","article-title":"Value of pneumococcal vaccination in controlling the development of antimicrobial resistance (AMR): case study using DREAMR in Ethiopia","volume":"39","author":"Ozawa","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129226_bb0235","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1377\/hlthaff.2017.0861","article-title":"The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries","volume":"37","author":"Chang","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129226_bb0240","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amepre.2018.09.020","article-title":"Cost effectiveness of meningococcal serogroup B vaccination in college-aged young adults","volume":"56","author":"Leeds","year":"2019","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/13696998.2022.2026118","article-title":"The societal economic value of COVID-19 vaccines in the United States","volume":"25","author":"Kirson","year":"2022","journal-title":"J Med Econ"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129226_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008805","article-title":"The economic impact and cost-effectiveness of combined vector-control and dengue vaccination strategies in Thailand: results from a dynamic transmission model","volume":"14","author":"Knerer","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129226_bb0255","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40273-017-0487-3","article-title":"The potential cost effectiveness of different dengue vaccination programmes in Malaysia: a value-based pricing assessment using dynamic transmission mathematical modelling","volume":"35","author":"Shafie","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129226_bb0260","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.vaccine.2023.01.068","article-title":"The societal value of SARS-CoV-2 booster vaccination in Indonesia","volume":"41","author":"Johnson","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129226_bb0265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.vaccine.2022.11.074","article-title":"Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China","volume":"41","author":"Chen","year":"2023","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2026.129226_bb0270","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.vaccine.2021.07.029","article-title":"Cost-benefit analysis of vaccination against four preventable diseases in older adults: impact of an aging population","volume":"39","author":"Carrico","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129226_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282972","article-title":"Cost-effectiveness of expanded hepatitis A vaccination among adults with diagnosed HIV, United States","volume":"18","author":"Abimbola","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0280","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","article-title":"Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"51","key":"10.1016\/j.vaccine.2026.129226_bb0285","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1016\/j.vaccine.2017.10.058","article-title":"Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan","volume":"36","author":"Anwari","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129226_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183306","article-title":"Re\u2013evaluation of the cost\u2013effectiveness and effects of childhood rotavirus vaccination in Norway","volume":"12","author":"Hansen Edwards","year":"2017","journal-title":"PloS One"},{"issue":"52","key":"10.1016\/j.vaccine.2026.129226_bb0295","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1016\/j.vaccine.2019.09.084","article-title":"Estimating the economic impact of pneumococcal conjugate, haemophilus influenzae type b and rotavirus vaccines in India: national and state-level analyses","volume":"37","author":"Constenla","year":"2019","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2026.129226_bb0300","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1016\/j.vaccine.2021.09.075","article-title":"Cost-effectiveness of rotavirus vaccination in the Philippines: a modeling study","volume":"39","author":"Villanueva-Uy","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129226_bb0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S0266462320000069","article-title":"Estimating the fiscal impact of three vaccination strategies in Italy","volume":"36","author":"Ruggeri","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"issue":"21","key":"10.1016\/j.vaccine.2026.129226_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192113789","article-title":"Cost-benefit analysis of interventions to mitigate the monkeypox virus","volume":"19","author":"Alshahrani","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"16","key":"10.1016\/j.vaccine.2026.129226_bb0350","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.16.2400652","article-title":"Sociodemographic inequalities in the epidemiology and vaccine uptake within a large outbreak of measles in Birmingham, England, 2023 to 2024","volume":"30","author":"Jary","year":"2025","journal-title":"Euro Surveill"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129226_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004764","article-title":"Financial risk protection from vaccines in 52 Gavi-eligible low- and middle-income countries: a modeling study","volume":"22","author":"Jiao","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.129226_bb0360","series-title":"Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use: technical report","first-page":"16","year":"2024"},{"key":"10.1016\/j.vaccine.2026.129226_bb0365","unstructured":"Revolving Fund Vaccine Prices 2025 - PAHO\/WHO | Pan American Health Organization [Internet]. [cited 2026 Mar 6]. Available from: https:\/\/www.paho.org\/en\/documents\/revolving-fund-vaccine-prices-2025."},{"key":"10.1016\/j.vaccine.2026.129226_bb0370","unstructured":"IrenaV. Informality and Households' Vulnerabilities in Latin America Data, Insights And Implications For Labour Formalisation Policies [Internet]. 2020 [cited 2026 Mar 6]. Available from: www.oecd.org\/about\/publishing\/corrigenda.htm."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.129226_bb0375","article-title":"The value of productivity: human-capital versus friction-cost method","volume":"69","author":"Van Den Hout","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129226_bb0380","article-title":"Realising the broader value of vaccines in the UK","volume":"1","author":"Brassel","year":"2021","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2026.129226_bb0385","unstructured":"Vaccines and immunization [Internet]. [cited 2026 Mar 6]. Available from: https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1."},{"key":"10.1016\/j.vaccine.2026.129226_bb0390","author":"Immunization across the life course - Resource center - PAHO\/WHO | Pan American Health Organization [Internet]"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129226_bb0395","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/vaccines12080852","article-title":"A structured narrative literature review of the broader value of adult immunisation programmes","volume":"12","author":"El Banhawi","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129226_bb0400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40273-014-0132-3","article-title":"How to estimate productivity costs in economic evaluations","volume":"32","author":"Krol","year":"2014","journal-title":"PharmacoEconomics"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0405","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14760584.2024.2387599","article-title":"The broader benefits of vaccines: methodologies for inclusion in economic evaluation","volume":"23","author":"Simoens","year":"2024","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0410","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02929-0","article-title":"The full value of vaccine assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making","volume":"21","author":"Hutubessy","year":"2023","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0415","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40258-021-00683-z","article-title":"Towards a broader assessment of value in vaccines: the BRAVE way forward","volume":"20","author":"Bell","year":"2022","journal-title":"Appl Health Econ Health Policy"},{"issue":"46","key":"10.1016\/j.vaccine.2026.129226_bb0430","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1016\/j.vaccine.2017.09.048","article-title":"Estimating the full public health value of vaccination","volume":"35","author":"Gessner","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0420","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12916-018-1130-7","article-title":"Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks","volume":"16","author":"Park","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0425","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14760584.2024.2387599","article-title":"The broader benefits of vaccines: methodologies for inclusion in economic evaluation","volume":"23","author":"Simoens","year":"2024","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129226_bb0435","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.vaccine.2019.12.009","article-title":"Understanding the role of peace of mind in childhood vaccination: a qualitative study with members of the general public","volume":"38","author":"Lasseter","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129226_bb0440","series-title":"A guide to social return on investment","author":"Nicholls","year":"2012"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129226_bb0445","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-1935-7","article-title":"Social return on investment (SROI) methodology to account for value for money of public health interventions: a systematic review","volume":"15","author":"Banke-Thomas","year":"2015","journal-title":"BMC Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:56:09Z","timestamp":1793922969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":75,"alternative-id":["S0264410X26010352"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129226","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the broader social value outcomes reported in economic evaluations of vaccination programmes across the life course: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan American Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129226"}}